This month in APR.
Kang
Keon Wook
KW
D000818:Animals; D022782:CCAAT-Enhancer-Binding Protein-beta / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects*; D019927:Cyclin E / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006498:Hepatectomy; D017228:Hepatocyte Growth Factor / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000201:enzymology / Q000601:surgery; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D008115:Liver Regeneration / Q000187:drug effects*; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D011719:Pyrazines / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D038762:Ribosomal Protein S6 Kinases, 70-kDa / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013871:Thiones; D013876:Thiophenes; D013997:Time Factors
D022782:CCAAT-Enhancer-Binding Protein-beta; D019927:Cyclin E; D017228:Hepatocyte Growth Factor; D019869:Phosphatidylinositol 3-Kinases; D011719:Pyrazines; D038762:Ribosomal Protein S6 Kinases, 70-kDa; D013871:Thiones; D013876:Thiophenes; C026209:oltipraz